Stock ORTX ORCHARD THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Orchard Therapeutics plc

Equities

ORTX

US68570P2002

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List
AQ
FDA Approves First Gene Therapy To Treat Children With Metachromatic Leukodystrophy
AQ
FDA approves innovative gene therapy for MLD
AQ
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
AQ
Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.
AQ
Orchard Therapeutics Receives FDA Approval of Lenmeldy? (atidarsagene autotemcel)
CI
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
AQ
Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
CI
Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
AQ
Kyowa Kirin Co., Ltd - Notice regarding Completion of Share Acquisition of Orchard Therapeutics plc
AQ
Japanese Shares Skid as Inflation Slows Faster-than-Expected in January
MT
Kyowa Kirin Acquires All Outstanding Shares of Orchard Therapeutics
MT
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
AQ
Orchard Therapeutics plc Announces Board Changes
CI
Orchard Therapeutics Completes Sale to Japan's Kyowa Kirin
MT
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
AQ
Orchard Therapeutics plc(NasdaqCM:ORTX) dropped from NASDAQ Composite Index
CI
Kyowa Kirin Co., Ltd. completed the acquisition of Orchard Therapeutics plc from RA Capital Management, L.P., Deep Track Capital, LP, Zentree Investment Management Pte. Ltd. and others.
CI
Orchard Therapeutics’ Gene Therapy Gets Swiss Regulatory Approval
MT
Orchard Therapeutics Receives Swissmedic Approval for Libmeldy in Early-onset MLD
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORTX Stock
  4. News Orchard Therapeutics plc